Impact of significant chronic kidney disease on long-term clinical outcomes after drug-eluting stent versus bare metal stent implantation

International Journal of Cardiology

Volumn 125, Issue 1, 2008, Pages 36-40

  Jeong, Young Hoon ^a   Hong, Myeong Ki ^a   Lee, Cheol Whan ^a   Park, Duk Woo ^a   Kim, Young Hak ^a   Kim, Jae Joong ^a   Park, Seong Wook ^a   Park, Seung Jung ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Chronic kidney disease; Stents

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; CLOPIDOGREL; INSULIN; PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ARTICLE; BLOOD VESSEL DIAMETER; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE CLEARANCE; DIABETES MELLITUS; DRUG EFFICACY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEMODIALYSIS; HUMAN; INTERMETHOD COMPARISON; LOADING DRUG DOSE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METAL IMPLANTATION; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PERITONEAL DIALYSIS; PRIORITY JOURNAL; REVASCULARIZATION; SIDE EFFECT; UNSPECIFIED SIDE EFFECT;

CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PACLITAXEL; RENAL ARTERY OBSTRUCTION; RETROSPECTIVE STUDIES; RISK FACTORS; SIROLIMUS; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 39749098701     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.02.026     Document Type: Article

References (21)

1. Jones C.A., McQuillan G.M., Kusek J.W., et al. Serum creatinine levels in the U.S. population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 32 (1998) 992-999
2. National Institute of Diabetes and Digestive and Kidney Diseases. Renal data system. USRDS 2000 Annual Data Report (2000), Bethesda, MD 583-689
3. Kahn J.K., Rutherford B.D., McConahay D.R., et al. Short- and long-term outcome of percutaneous transluminal coronary angioplasty in chronic dialysis patients. Am Heart J 119 (1990) 484-489
4. Schoebel F.C., Gradaus F., Ivens K., et al. Restenosis after elective coronary balloon angioplasty in patients with end-stage renal disease: a case-control study using quantitative coronary angiography. Heart 78 (1997) 337-342
5. Nikolsky E., Mehran R., Turcot D., et al. Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention. Am J Cardiol 94 (2004) 300-305
6. Blackman D.J., Pinto R., Ross J.R., et al. Impact of renal insufficiency on outcome after contemporary percutaneous coronary intervention. Am Heart J 151 (2006) 146-152
7. Lemos P.A., Saia F., Hofma S.H., et al. Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction. J Am Coll Cardiol 43 (2004) 704-708
8. Colombo A., De Gregorio J., Moussa I., et al. Intravascular ultrasound-guided percutaneous transluminal coronary angioplasty with provisional spot stenting for treatment of long coronary lesions. J Am Coll Cardiol 38 (2001) 1427-1433
9. Chieffo A., Stankovic G., Bonizzoni E., et al. Early and mid-term results of drug eluting stent implantation in unprotected left main. Circulation 111 (2005) 791-795
10. Degertekin M., Regar E., Tanabe K., et al. Sirolimus-eluting stent for treatment of complex in-stent restenosis: the first clinical experience. J Am Coll Cardiol 41 (2003) 184-189
11. Alban D., Adnan K., and Julinda M. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med 353 (2005) 663-670
12. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
13. Luke R.G. Chronic renal failure; a vasculopathic state. N Engl J Med 339 (1998) 841-843
14. Best P.J.M., Lennon R., Ting H.H., et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 39 (2002) 1113-1139
15. Herzog C.A., Ma J.Z., and Collins A.J. Long-term outcome of dialysis patients in the United States with coronary revascularization procedures. Kidney Int 56 (1999) 324-332
16. Malanuk R.M., Nielsen C.D., Theis P., et al. Treatment of coronary artery disease in hemodialysis patients: PTCA vs. stent. Catheter Cardiovasc Interv 54 (2001) 459-463
17. Best P.J.M., Berger P.B., Davis B.R., et al. Impact of mild or moderate chronic kidney disease on the frequency of restenosis. J Am Coll Cardiol 44 (2004) 1786-1791
18. Reddan D.N., Szczech L.A., Tuttle R.H., et al. Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. J Am Soc Nephrol 14 (2003) 2373-2380
19. London G.M. Cardiovascular disease in chronic renal failure: pathophysiologic aspects. Semin Dial 16 (2003) 85-94
20. Gruberg L., Dangas G., Mehran R., et al. Clinical outcome following percutaneous coronary intervention in patients with chronic renal failure. Catheter Cardiovasc Interv 55 (2002) 66-72
21. Halkin A., Mehran R., Casey C.W., et al. Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: results from the TAXUS-IV Trial. Am Heart J 150 (2005) 1163-1170